CoChat

The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon‐like peptide‐1 release

Open access
Ong, WK, Gribble, FM, Reimann, F, Lynch, MJ, Houslay, MD, Baillie, GS, Furman, BL, Pyne, NJ · 2009 · British Journal of Pharmacology
Cited by 66

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background and purpose: Increases in intracellular cyclic AMP (cAMP) augment the release/secretion of glucagon‐like peptide‐1 (GLP‐1). As cAMP is hydrolysed by cAMP phosphodiesterases (PDEs), we determined the role of PDEs and particularly PDE4 in regulating GLP‐1 release. Experimental approach: GLP‐1 release, PDE expression and activity were investigated using rats and GLUTag cells, a GLP‐1‐releasing cell line. The effects of rolipram, a selective PDE4 inhibitor both in vivo and in vitro and stably overexpressed catalytically inactive PDE4D5 (D556A‐PDE4D5) mutant in vitro on GLP‐1 release were investigated. Key results: Rolipram (1.5 mg·kg−1 i.v.) increased plasma GLP‐1 concentrations approximately twofold above controls in anaesthetized rats and enhanced glucose‐induced GLP‐1 release in GLUTag cells (EC 50∼1.2 nmol·L−1). PDE4D mRNA transcript and protein were detected in GLUTag cells using RT‐PCR with gene‐specific primers and Western blotting with a specific PDE4D antibody respectively. Moreover, significant PDE activity was inhibited by rolipram in GLUTag cells. A GLUTag cell clone (C1) stably overexpressing the D556A‐PDE4D5 mutant, exhibited elevated intracellular cAMP levels and increased basal and glucose‐induced GLP‐1 release compared with vector‐transfected control cells. A role for intracellular cAMP/PKA in enhancing GLP‐1 release in response to overexpression of D556A‐PDE4D5 mutant was demonstrated by the finding that the PKA inhibitor H89 reduced both basal and glucose‐induced GLP‐1 release by 37% and 39%, respectively, from C1 GLUTag cells. Conclusions and implications: PDE4D may play an important role in regulating intracellular cAMP linked to the regulation of GLP‐1 release. British Journal of Pharmacology (2009) 157, 633–644; doi:10.1111/j.1476‐5381.2009.00194.x; published online 9 April 2009

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2009.00194.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 66

Metadata

Authors
Ong, W., Gribble, F., Reimann, F., Lynch, M., Houslay, M., Baillie, G., Furman, B., & Pyne, N.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2009-06
Volume
157
Issue
4
Pages
633-644
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1550156414
Cited by
66
References
2
FWCI
1.20
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon‐like peptide‐1 release. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00194.x
The paper
Ong, W., Gribble, F., Reimann, F., Lynch, M., Houslay, M., Baillie, G., Furman, B., & Pyne, N. (2009). The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon‐like peptide‐1 release. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00194.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.